SAN FRANCISCO, July 7, 2015 /PRNewswire/ -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its latest version of goBalto Activate. The second major release of 2015 offers new features that further accelerate clinical study startup.
"There is intense pressure to speed clinical trials and restrain costs, with Sponsors and CROs continuing to search for ways to automate and reduce the time it takes to get investigative sites up and running," said Sujay Jadhav, goBalto's CEO. "goBalto is the industry standard for study startup, completing the eClinical Stack with full integration to existing CTMS and eTMF systems, enabling business process optimization, oversight and continual process improvements that existing systems don't address."
"The clinical trials industry recognizes that study startup is one of the most difficult areas today resulting in delays and high costs. Our initial research in this area shows that the study startup process is very unsophisticated and inefficient," said Ken Getz, Director, Tufts Center for the Study of Drug Development. "Sponsor organizations are typically struggling to identify and engage a global community of investigative sites quickly; to review and approve regulatory documentation in a timely manner; to manage costs, resources and timelines."
With over 2,000 pharmaceutical and CRO users in more than 60 countries using Activate to manage, track, and complete study startup tasks, goBalto has the largest industry-proven set of country workflows. Our standard 'out-of-the-box' country specific regulatory business process workflows allow quick site activation, leading to greater cost savings and faster market entry, making valuable therapies available to patients sooner.
"This release illustrates our commitment to our customers as we continue to support them accelerate the development of drugs that save lives and improve the quality of life," said Jadhav. "We now service three of the top 5 CROs and more than two-thirds of the top 20 pharma's, managing their clinical trial documents globally."
Activate customers report improved business performance and a reduction in cycle times by > 30%. New capabilities just released aim to improve project management capabilities and usability, with a focus on enhanced risk management, utilization, business process improvement, and administration. Activate's new features include:
- milestone re-planning indicators to improve cycle times
- automatic/intelligent distribution of study documents
- advanced study status management tool supporting complete clinical lifecycle
- enhanced single sign-on (SSO) enabling streamlined integration with adjoining customer systems
goBalto develops next-generation solutions that simplify and accelerate clinical study startup in the pharmaceutical, biotechnology, and medical device industries. Our management team has over 100 years of combined experience in the life sciences industry and enterprise software implementation. Our team has worked for such companies as Amgen, Genentech, Quintiles, Roche, Johnson & Johnson, and Model N. With a proven commitment to customer success, disruption, and study startup optimization, we're changing the way our leading global pharma and CRO customers approach their business processes. Based in San Francisco, California, we have satellite offices in Pennsylvania and Singapore. For more information, visit www.gobalto.com.
SOURCE goBalto, Inc.